Join the NIH NIBIB DEBUT Challenge 2026: Up to $170,000 in Prizes for Undergraduate Biomedical Teams
The 2026 DEBUT Challenge from NIH NIBIB is an undergraduate-focused biomedical design competition with cash prizes, commercialization support, and a nationwide submission cycle ending June 5, 2026.
Join the NIH NIBIB DEBUT Challenge 2026: Up to $170,000 in Prizes for Undergraduate Biomedical Teams
The National Institute of Biomedical Imaging and Bioengineering (NIBIB) is running the 2026 Design by Biomedical Undergraduate Teams (DEBUT) Challenge as a full competition under NIH’s challenge model. It is designed for undergraduate teams building practical biomedical technology ideas, with clear prize money and structured commercialization support for top entries. This is not a grant application and it is not a fellowship with fixed institutional funding; it is a problem-driven design competition with submission-specific rules and judging.
The page is currently marked as open until June 5, 2026, 11:59 PM EDT. The same page also lists a $170,000 NIH prize pool and a total of five NIH partner categorical awards of $15,000 plus standard top prizes, with additional VentureWell prizes promised separately.
The practical framing is important: this challenge rewards teams that can pair a meaningful unmet clinical need with a concrete, working prototype and clear communication. If your team can meet the filing process and present a concise engineering solution, this is one of the more practical national-level opportunities for undergraduates.
Key details
| Item | Detail |
|---|---|
| Opportunity | 2026 DEBUT Challenge |
| Funding type | Challenge with cash prizes |
| Total NIH cash value | Up to $170,000 |
| Main prizes | $20,000 / $15,000 / $10,000 |
| Categorical prizes | Eight awards at $15,000 each |
| Honorable mentions | Up to five at $1,000 each |
| Extra prizes | VentureWell has indicated up to $20,000 (separate partner award; not guaranteed from NIH) |
| Submission close | June 5, 2026, 11:59 PM EDT |
| Entry window | January 15, 2026 to June 5, 2026 |
| Team size | 3 to 8 members |
| Main eligibility anchor | Undergraduate students on full-time enrollment during the 2025-2026 academic year |
| Submission format | One PDF containing specific required sections |
| Official source | NIH Challenges and Prize Competitions |
What this opportunity offers and what it does not offer
The DEBUT Challenge is often misunderstood as either a startup grant or an informal design contest. In practice, it is a structured NIH challenge with explicit judging criteria. You are applying for a competition entry, not an open grant budget. If your project requires a traditional grant model with milestones and award letters, this may not fit. If you have a prototype-focused undergraduate design team, this does.
What it offers:
- Monetary outcomes, with clear prize levels.
- Access to a commercialization pathway: all NIH winners and honorable mentions are eligible for a dC3i Phase 1 commercialization training series.
- Optional Phase 2 access for a small subset based on completion and quality of coursework.
- Visibility through NIH/BMES recognition where teams are honored at award events.
What it does not offer:
- Guaranteed funding for every entrant.
- Direct research grants for broad project costs.
- A standard proposal review cycle with budget justification language.
- Guaranteed partner prizes from VentureWell (the page explicitly says they are intent-driven and separate from NIH).
The distinction matters because teams often waste cycles collecting materials irrelevant to the page’s structure. This challenge is submission-driven, so it punishes unclear scope and rewards concrete deliverables: a strong narrative, project details, prototype proof, and judge-ready technical clarity.
Who should apply
This opportunity is specifically crafted around undergrad teams that can move beyond concept papers into implemented biomedical design. It strongly favors teams with mix skills:
- engineering or biomedical design leadership,
- clinical or user problem insight,
- fabrication/testing capability,
- and someone comfortable writing clearly under competition constraints.
The strongest teams are interdisciplinary. Teams from biomedical engineering, bioengineering, mechanical, electrical, and software backgrounds plus healthcare-focused teammates can outperform single-discipline teams because judging and evaluation favor function and practicality over only technical elegance.
The challenge is suitable for:
- Capstone teams,
- student innovation labs,
- multidisciplinary class-based teams,
- and teams already piloting device concepts.
The NIH language explicitly says capstone teams are especially encouraged. If your group is at early ideation, you are not excluded, but you need evidence of need validation and design feasibility by submission time. Teams that can document at least prototype behavior or test results are significantly more competitive.
For this reason, non-final-year teams should only apply if they have timeline confidence and clear faculty backing. Fresh ideas can compete, but teams without practical build evidence are often at a disadvantage because one judging pillar is whether a working prototype has been achieved.
Eligibility and non-obvious constraints you must respect
The official rules specify a few constraints that are easy to miss:
Team size and membership. A Student Team must include at least three and no more than eight individuals. It is not a solo competition.
Student status. Every team member must be a full-time undergraduate on a U.S. college or university curriculum for at least one full semester/quarter in the 2025-2026 academic year. This is a direct filter. If your team has part-time or gap-semester members, those members can’t satisfy this condition.
Citizenship and prize eligibility.
- To receive prize funds from NIH, members must be U.S. citizens or permanent residents.
- Non-U.S. citizens studying in the U.S. can still be part of a team and may contribute to a winning entry, but they do not receive monetary distribution.
- They are still listed as winners and can participate in commercialization support tracks.
- Academic alignment.
- Teams from institutions with biomedical engineering or bioengineering departments need at least one member in that major area.
- That requirement is explicitly waived for institutions without a formal department.
- Team Captain requirements.
- A Team Captain must be the primary liaison.
- This person must be a U.S. citizen or permanent resident.
- NIH treats only official Team Captain communication as official.
One submission rule. Each team can submit only one entry.
Integrity and ownership rule.
- The entry must be conceived and designed by the team.
- Heavy outside contribution can lead to disqualification.
- Non-compete and compliance controls.
- Judges, challenge organizers, family members, and certain federal employee categories are excluded in specific capacities.
- Teams must use an official certification form and satisfy all terms. Missing that form invalidates entries.
- Data and IP control.
- Teams must have rights to any third-party code, patents, images, or materials used.
This makes DEBUT a highly compliant competition for engineering teams, with little room for sloppy documentation.
Eligibility interpretation by case type
You can think of three practical candidate types:
- Campus-only teams (all members from same school): easiest to coordinate sponsor letter and documentation.
- Cross-institution teams: allowed, but sponsor letters and enrollment proof become more complex.
- Cross-country teams: possible in principle, but only U.S. citizen/permanent residents can receive cash.
For teams with non-U.S. members, clarify early that the team can still pursue technical recognition but not U.S. cash distribution unless all members qualify. This matters for role assignment and internal expectations.
Why teams win: judging lens and scoring behavior
NIH staff and external experts review entries with a focused structure:
- Significance: Is the problem real, urgent, and clearly explained?
- Impact: Is uptake by users and clinicians plausible? Are workflow and utility credible?
- Innovative design: Is the solution novel or significantly better than current methods?
- Prototype evidence: Is there demonstrable implementation, not just concept slides?
- Implementation logic: Is the solution robust and feasible under real constraints?
NIH explicitly calls for clinician/user input in the problem framing, so a design that cites actual interviews, observations, or test context usually scores better than an abstract problem statement. If your innovation addresses one of the eight partner categories, your submission should still state the primary application story clearly.
Application package and required materials
The entry is a single PDF file, and this is where many teams underperform because they submit long, disorganized documents.
Required components
- Certification form
- Must be included.
- Includes team details and citizenship/permanent residency status, plus signatures.
- Missing form details can disqualify entries.
- Project narrative (max 6 pages)
- Arial, minimum 11pt.
- Sections include Abstract, clinical need description, objective statement, design documentation, prototype documentation, and a 3-minute project video link.
- If the project is part of an ongoing broader class project, the team must explain what was designed independently.
- Sponsor letter from faculty or designated equivalent
- Confirms original team work and full-time status.
- Required for U.S. institutions with biomedical/ bioengineering departments and for teams without those departments.
- Parental consent form for under-18 members
- Required if any member is under 18.
Optional supporting material (judge’s discretion)
- up to three support letters,
- up to three background references,
- and links to videos/web resources.
Optional material will not replace weak core sections. Treat optional files as proof amplification only, not a substitute for the required narrative.
Practical preparation plan: from idea to competitive entry
Teams usually fail for process reasons rather than idea quality. A practical plan:
Week 0-2: Problem lock and role split
- Choose one clinical problem only.
- Assign engineering, documentation, testing, and sponsor-communication roles.
Week 3-4: Evidence gathering
- Interview users and collect workflow context.
- Write one paragraph for every design decision tied to observed need.
Week 5-6: Prototype and testing design
- Build a minimal operational demonstration.
- Define how efficacy is measured even in a simple bench or simulated setting.
Week 7-8: Draft narrative and required sections
- Fill all mandatory headings exactly.
- Keep terminology non-technical enough for judges outside your narrow lab.
Week 9: Compliance pass
- Add Certification form, sponsor letter, and signatures.
- Confirm all dates and spellings.
- Ensure PDF page limit.
Week 10: Platform and upload test
- Register once early using the provided Team Captain flow.
- Confirm only one entry path and final file name consistency.
- Submit early enough to buffer platform issues.
Use the 3-minute video sparingly: show problem, design, and prototype behavior. Long conceptual slides without visual outcome often underperform.
Common mistakes that hurt teams
- Missing or incomplete certification form.
- Submitting a large PDF that exceeds the page limit.
- Using non-cash team members without defining contribution and expectation split.
- Not distinguishing what your team built versus advisor work.
- Overusing buzzwords and under-documenting clinical relevance.
- Ignoring sponsor letter requirements due to late coordination.
- Forgetting to include the 3-minute video link where expected.
Judges are balancing innovation quality with evidence. A prototype without usage context can still be compelling if your testing method is clear. Conversely, perfect writing without proof is often rejected.
How this helps versus a typical grant application
In a standard NIH grant, reviewers compare against prior work and budget logic over years. In DEBUT, speed and signal quality matter more. You need a proof-to-evidence ratio that proves your team did real work. Teams that can present:
- a specific unmet need,
- a technical concept,
- a working proof,
- and realistic commercialization framing
have a meaningful edge.
A second difference is geography and eligibility economics. NIH allows broader team composition, including international students, but ties award distribution to citizenship/permanent-residency status. That means teams should be explicit internally about expectations.
Financial and support outcomes you should expect
The headline cash value is clear in categories:
- top three prizes at $20,000/$15,000/$10,000,
- several categorical awards at $15,000,
- and honorable mentions worth $1,000.
Additional commercialization value can be more strategic than money:
- dC3i Phase 1 training,
- potential Phase 2 training slots for top performers,
- possible in-kind opportunities like NIH campus exposure,
- and early market-facing feedback.
These program-side outcomes often produce stronger outcomes than short-term prize size, especially if your team is aiming for commercialization.
Frequently asked questions
Is this open now? Yes. The official page shows it was open until 06/05/2026 11:59 PM EDT.
Can a student team include members not on a U.S. team? Yes. The rules focus on participation, while cash-prize eligibility is limited to U.S. citizens/permanent residents.
Can we submit a prior project? Yes, with restrictions. Teams may resubmit prior-year entries only under narrow no-prize-history conditions.
Can winning teams submit again later? Past winning teams may re-enter only with a different entry.
Can only one submission per institution be made? No, one submission per team. Institutions can have multiple teams if they independently satisfy rules.
What is required in the project narrative? The core elements are a concise abstract, need description, objectives, design, prototype documentation, and video link, with strict page limits.
Is this suitable for students without medical training? Yes, if the team includes the right technical and clinical insight roles.
Official links and next steps
Primary pages to use now:
- Official NIH DEBUT announcement: https://www.nih.gov/challenges/2026-design-biomedical-undergraduate-teams-debut-challenge
- NIBIB DEBUT landing page: https://www.nibib.nih.gov/programs/division-interdisciplinary-training-didt/debut
- VentureWell DEBUT registration and guidelines: https://venturewell.org/debut/
If you are deciding this cycle, the best move is to treat the deadline as fixed and begin the administrative setup immediately. Most teams with strong designs still lose due to missing certifications, incomplete status proof, and submission-process mistakes.
Use this competition as a proving ground if your project can show user relevance, prototyping quality, and coherent communication. Under those conditions, DEBUT works as a credible launch point between classroom design and real health technology execution.
